VELOXIS PHARMACEUTICALS A/S: Financial statements 2014
CVR: 26527767
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
VELOXIS PHARMACEUTICALS A/S (CVR 26527767) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 123,395,000 and a net result of DKK -36,319,000. The profit margin was -29.4%. Equity in the 2014 report amounted to DKK 253,248,000. The solvency ratio was 86.2%.
- Revenue
- DKK 123,395,000
- Gross Profit
- DKK 120,148,000
- Profit/Loss
- DKK -36,319,000
- Equity
- DKK 253,248,000
- Total Assets
- DKK 293,723,000
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
VELOXIS PHARMACEUTICALS A/S has published its interim report for the period July 1, 2014 to September 30, 2014.
VELOXIS PHARMACEUTICALS A/S has published its interim report for the period January 1, 2014 to March 31, 2014.
VELOXIS PHARMACEUTICALS A/S has published its interim report for the period January 1, 2014 to June 30, 2014.
VELOXIS PHARMACEUTICALS A/S has published its annual report for 2013.
About VELOXIS PHARMACEUTICALS A/S
VELOXIS PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LIFECYCLE PHARMA A/S and PHAROTECH A/S. The management consists of Daisuke Matsuo. The board consists of Keigo Nakatsukasa (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. The company has 1 employee (2022). In 2026, the company reported a net result of DKK -1,553,000. Equity in the 2026 report amounted to DKK 611,587,000.